News
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot water. U.K drug marketing watchdog the PMCPA ruled the network login process, which directed users to Gilead’s U ...
Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney's Office in Manhattan, which ...
During Gilead’s (NASDAQ:GILD) recent earnings call, CEO Daniel O’Day pointed out that the company’s nearly 20% corporate tax rate “reflects the fact that the substantial majority of our ...
Nikos Pekiaridis / NurPhoto via Getty Images Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined. The biopharma's profit got a lift from ...
Headquartered in Foster City, CA, Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus (HIV). The company’s broad portfolio includes drugs for liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results